Milestone Pharmaceuticals Inc. (MIST)

NASDAQ: MIST · IEX Real-Time Price · USD

1.350

0.00 (0.00%)

At close: Jul 2, 2024, 3:59 PM

1.320

-0.030 (-2.22%)

After-hours: Jul 2, 2024, 7:49 PM EDT

Milestone Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	72	56	136	196	200	392
Market Cap Growth	-27.46%	-58.82%	-30.61%	-2.08%	-49.04%	-
Enterprise Value	35	42	74	82	58	273
PE Ratio	-	-0.94	-2.33	-4.57	-4.00	-7.10
PS Ratio	-	55.92	27.16	13.04	-	-
PB Ratio	1.80	3.33	2.05	1.74	1.40	3.41
P/FCF Ratio	-2.29	-1.20	-2.57	-5.89	-3.94	-7.60
P/OCF Ratio	-2.30	-1.20	-2.59	-5.89	-3.94	-7.67
EV/Sales Ratio	-	41.69	14.74	5.48	-	-
EV/EBITDA Ratio	-1.13	-0.73	-1.26	-1.92	-1.17	-4.94
EV/EBIT Ratio	-1.13	-0.73	-1.26	-1.92	-1.17	-4.94
EV/FCF Ratio	-1.40	-0.90	-1.40	-2.47	-1.15	-5.29
Debt / Equity Ratio	1.32	3.09	0.04	0.01	0.01	0.00
Debt / EBITDA Ratio	-1.02	-0.91	-0.04	-0.02	-0.02	-0.01
Debt / FCF Ratio	-1.26	-1.11	-0.05	-0.02	-0.02	-0.01
Quick Ratio	22.01	9.58	10.66	16.87	23.14	14.42
Current Ratio	22.75	10.11	11.70	17.55	24.14	14.71
Asset Turnover	0	0.01	0.06	0.11	0	0
Interest Coverage	-15.25	-22.37	-	-	-	-
Return on Equity (ROE)	-175.40%	-171.00%	-70.60%	-33.50%	-46.20%	-67.40%
Return on Assets (ROA)	-62.00%	-64.40%	-65.40%	-31.90%	-43.70%	-44.70%
Return on Capital (ROIC)	-60.67%	-89.13%	-86.64%	-38.02%	-35.20%	-50.14%
Earnings Yield	-76.62%	-106.74%	-43.00%	-21.90%	-25.01%	-14.08%
FCF Yield	-57.77%	-83.22%	-38.85%	-16.98%	-25.39%	-13.15%
Buyback Yield / Dilution	-17.04%	-1.19%	-1.47%	-42.56%	-85.91%	-4845.07%
Total Shareholder Return	-17.04%	-1.19%	-1.47%	-42.56%	-85.91%	-4845.07%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).